Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in Nfkb2 Publisher Pubmed



Klemann C1, 2 ; Camachoordonez N2, 3 ; Yang L2 ; Eskandarian Z2 ; Rojasrestrepo JL2 ; Frede N2 ; Bulashevska A2 ; Heeg M2, 4 ; Alddafari MS2, 5 ; Premm J2 ; Seidl M2, 6 ; Ammann S2, 7 ; Sherkat R8 ; Radhakrishnan N9 Show All Authors
Authors
  1. Klemann C1, 2
  2. Camachoordonez N2, 3
  3. Yang L2
  4. Eskandarian Z2
  5. Rojasrestrepo JL2
  6. Frede N2
  7. Bulashevska A2
  8. Heeg M2, 4
  9. Alddafari MS2, 5
  10. Premm J2
  11. Seidl M2, 6
  12. Ammann S2, 7
  13. Sherkat R8
  14. Radhakrishnan N9
  15. Warnatz K10
  16. Unger S10
  17. Kobbe R11
  18. Hufner A12
  19. Ronan Leahy T13
  20. Ip W14, 15
  21. Burns SO16, 17
  22. Fliegauf M2, 18
  23. Grimbacher B2, 18
Show Affiliations
Authors Affiliations
  1. 1. Department of Pediatric Pneumology, Allergy and Neonatology, Hannover Medical School, Hannover, Germany
  2. 2. Faculty of Medicine, Center for Chronic Immunodeficiency (CCI), Medical Center, University of Freiburg, Freiburg, Germany
  3. 3. Faculty of Biology, University of Freiburg, Freiburg, Germany
  4. 4. Faculty of Medicine, Center for Pediatrics, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany
  5. 5. Laboratory of Applied Molecular Biology and Immunology, University of Tlemcen, Tlemcen, Algeria
  6. 6. Faculty of Medicine, Institute for Surgical Pathology, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany
  7. 7. Cambridge Institute for Medical Research, Cambridge, United Kingdom
  8. 8. Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  9. 9. Department of Pediatric Hematology Oncology, Super Speciality Pediatric Hospital, PG Teaching Institute, Noida, India
  10. 10. Faculty of Medicine, Division Immunodeficiency (CCI), Department of Rheumatology and Clinical Immunology, Medical Center, University of Freiburg, Freiburg, Germany
  11. 11. Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  12. 12. Infectious Disease Unit, Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  13. 13. Department of Paediatric Immunology and Infectious Diseases, Our Lady's Children's Hospital Crumlin, Dublin, Ireland
  14. 14. Infection, Immunity and Inflammation Theme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom
  15. 15. Department of Immunology, Great Ormond Street Hospital, London, United Kingdom
  16. 16. University College London Institute of Immunity and Transplantation, London, United Kingdom
  17. 17. Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom
  18. 18. CIBSS-Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany

Source: Frontiers in Immunology Published:2019


Abstract

Non-canonical NF-κB-pathway signaling is integral in immunoregulation. Heterozygous mutations in NFKB2 have recently been established as a molecular cause of common variable immunodeficiency (CVID) and DAVID-syndrome, a rare condition combining deficiency of anterior pituitary hormone with CVID. Here, we investigate 15 previously unreported patients with primary immunodeficiency (PID) from eleven unrelated families with heterozygous NFKB2-mutations including eight patients with the common p.Arg853* nonsense mutation and five patients harboring unique novel C-terminal truncating mutations. In addition, we describe the clinical phenotype of two patients with proximal truncating mutations. Cohort analysis extended to all 35 previously published NFKB2-cases revealed occurrence of early-onset PID in 46/50 patients (mean age of onset 5.9 years, median 4.0 years). ACTH-deficiency occurred in 44%. Three mutation carriers have deceased, four developed malignancies. Only two mutation carriers were clinically asymptomatic. In contrast to typical CVID, most patients suffered from early-onset and severe disease manifestations, including clinical signs of T cell dysfunction e.g., chronic-viral or opportunistic infections. In addition, 80% of patients suffered from (predominately T cell mediated) autoimmune (AI) phenomena (alopecia > various lymphocytic organ-infiltration > diarrhea > arthritis > AI-cytopenia). Unlike in other forms of CVID, auto-antibodies or lymphoproliferation were not common hallmarks of disease. Immunophenotyping showed largely normal or even increased quantities of naive and memory CD4+ or CD8+ T-cells and normal T-cell proliferation. NK-cell number and function were also normal. In contrast, impaired B-cell differentiation and hypogammaglobinemia were consistent features of NFKB2-associated disease. In addition, an array of lymphocyte subpopulations, such as regulatory T cell, Th17-, cTFH-, NKT-, and MAIT-cell numbers were decreased. We conclude that heterozygous damaging mutations in NFKB2 represent a distinct PID entity exceeding the usual clinical spectrum of CVID. Impairment of the non-canonical NF-κB pathways affects function and differentiation of numerous lymphocyte-subpopulations and thus causes a heterogeneous, more severe form of PID phenotype with early-onset. Further characteristic features are multifaceted, primarily T cell-mediated autoimmunity, such as alopecia, lymphocytic organ infiltration, and in addition frequently ACTH-deficiency. Copyright © 2019 Klemann, Camacho-Ordonez, Yang, Eskandarian, Rojas-Restrepo, Frede, Bulashevska, Heeg, Al-Ddafari, Premm, Seidl, Ammann, Sherkat, Radhakrishnan, Warnatz, Unger, Kobbe, Hufner, Leahy, Ip, Burns, Fliegauf and Grimbacher.